Skip to main content
. Author manuscript; available in PMC: 2023 May 2.
Published in final edited form as: Sex Transm Dis. 2021 Apr 1;48(4):222–231. doi: 10.1097/OLQ.0000000000001382

Table 1.

Summary of Model Parameters.

Parameter* Population/Characteristic Median (25th, 75th percentile) Distribution Form Strength of Input References
Population size (N) Men
15–24 years
25–39 years

Women
15–24 years
25–39 years

22,076,120
33,757,505


21,025,717
33,171,851
N/A (unvaried) II (13)
Number of case reports (κ) Chlamydia
Men
15–24 years
25–39 years

Women
15–24 years
25–39 years

Gonorrhea
Men
15–24 years
25–39 years

Women
15–24 years
25–39 years


306,110
246,601


779,367
318,246



116,427
167,134


132,291
90,786
N/A (unvaried) II (1)
Case reporting fraction (ρ) § 95.0% (93.8%, 96.2%) Uniform II (14)
Expert opinion
Proportion of cases that are asymptomatic (β) Chlamydia
Men
Women

Gonorrhea
Men
Women

83.9% (80.6%, 87.1%)
74.5% (71.6%, 77.5%)


41.3% (31.8%, 51.1%)
68.4% (61.8%, 74.2%)
Uniform III (4)
Background screening percent (per year, σ) Men
15–24 years
25–39 years

Women
15–24 years
25–39 years

14.4% (13.5%, 15.3%)
17.6% (16.5%, 18.7%)


27.3% (26.1%, 28.4%)
31.1% (30.0%, 32.3%)
Normal II (15)
Time to natural clearance (days, 1/ψ) Chlamydia
Men
Women

Gonorrhea
Men
Women

361.4 (313.9, 423.4)
397.9 (376.0, 416.1)


45.5 (38.6, 54.4)
91.3 (77.3, 108.6)
Bootstrapped empirical data III (16, 1826)
Time from infection to symptomatic treatment seeking (days, 1/τ) ǁ Chlamydia
Men
Women

Gonorrhea
Men
Women

25.5 (20.4, 30.7)
49.4 (39.7, 58.9)


16.2 (13.8, 18.4)
31.8 (27.5, 36.2)
Composite: see Data Inputs Supplement III (4, 17);
Unpublished data from the STD Surveillance Network
(PS13–1306),
2016–2018
*

Not all parameters were used in all models. See the Data Inputs Supplement and Mathematical Modeling Supplement for more information on which parameters were used in which estimates.

The 25th and 75th percentiles were generated either parametrically by sampling from the listed probability distribution for each variable or non-parametrically using bootstrapping techniques. The details of this process are explained in the Supplemental Materials. For any variables with no uncertainty interval provided, no variability was assumed.

The strength of the inputs used to inform model parameters was assessed using a rating system adapted from Satterwhite, et al and Lefevre, et al, the criteria for which are provided in the Data Inputs Supplement. (7, 40s)

§

The case reporting fraction represents the proportion of all diagnosed cases that are reported to the Centers for Disease Control and Prevention.

ǁ

The time from infection to symptomatic treatment seeking parameter is a function of multiple inputs. These included the probability of a person never seeking treatment, the time from infection acquisition to symptom onset, and time from symptom onset to testing due to symptoms. Refer to the Data Inputs Supplement for more information on how these components were combined to create this composite parameter.